0001209191-23-005476.txt : 20230130
0001209191-23-005476.hdr.sgml : 20230130
20230130162218
ACCESSION NUMBER: 0001209191-23-005476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221125
FILED AS OF DATE: 20230130
DATE AS OF CHANGE: 20230130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kung Winston
CENTRAL INDEX KEY: 0001666963
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39539
FILM NUMBER: 23568077
MAIL ADDRESS:
STREET 1: C/O PMV PHARMACEUTICALS, INC.
STREET 2: 8 CLARKE DRIVE, SUITE 3
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001699382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463218129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 642-6664
MAIL ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-25
0
0001699382
PMV Pharmaceuticals, Inc.
PMVP
0001666963
Kung Winston
C/O PMV PHARMACEUTICALS, INC.
ONE RESEARCH WAY
PRINCETON
NJ
08540
0
1
0
0
COO, CFO
Common Stock
2022-11-25
5
G
0
E
2560
0.00
D
10600
D
The reported shares were acquired under the Issuer's stock purchase plan on November 20, 2022.
/s/ Winston Kung
2022-01-30